Brinkmann, Ulrich
Roche Pharma AG,
Germany
2025 Rank: 55844
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2136 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55844 | 53628 |
| Total Cites | 12612 | 14110 |
| H-index | 51 | 56 |
| Hm-index | 18 | 21 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 98 | 106 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 2219 | 2528 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 6839 | 7527 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9168 | 9690 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.46 |
| Self-Citation Percentage |
10.62%
|
|
Brinkmann, Ulrich
Roche Pharma AG,
Germany
2024 Rank: 53167
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2135 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53167 | 51896 |
| Total Cites | 12068 | 13510 |
| H-index | 50 | 55 |
| Hm-index | 18 | 21 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 97 | 105 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 2139 | 2447 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 6541 | 7207 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8716 | 9226 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.46 |
| Self-Citation Percentage |
10.67%
|
|
Brinkmann, Ulrich
Roche Pharma AG,
Germany
2023 Rank: 52173
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2173 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52173 | 51772 |
| Total Cites | 11411 | 12805 |
| H-index | 49 | 54 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 95 | 103 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 2011 | 2315 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 6044 | 6680 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8168 | 8665 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.48 |
| Self-Citation Percentage |
10.89%
|
|
Brinkmann, Ulrich
Roche Pharma AG,
Germany
2022 Rank: 48814
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2139 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48814 | 47965 |
| Total Cites | 10860 | 12226 |
| H-index | 48 | 53 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 94 | 102 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 1890 | 2191 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 5701 | 6323 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7723 | 8209 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.49 |
| Self-Citation Percentage |
11.17%
|
|
Brinkmann, Ulrich
Roche Pharma AG,
Germany
2021 Rank: 50244
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2209 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50244 | 52015 |
| Total Cites | 10519 | 11827 |
| H-index | 48 | 52 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 71 | 75 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1783 | 2068 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 5491 | 6086 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7477 | 7949 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.49 |
| Self-Citation Percentage |
11.06%
|
|
Brinkmann, Ulrich
Roche Pharma AG,
Germany
2020 Rank: 47083
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2150 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47083 | 49178 |
| Total Cites | 9963 | 11209 |
| H-index | 48 | 51 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 70 | 74 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1640 | 1915 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 5125 | 5682 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7008 | 7459 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.50 |
| Self-Citation Percentage |
11.12%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.